BioAge Labs, Inc. (BIOA)
NASDAQ: BIOA · Real-Time Price · USD
11.61
+1.11 (10.57%)
At close: Dec 5, 2025, 4:00 PM EST
11.69
+0.08 (0.69%)
After-hours: Dec 5, 2025, 7:59 PM EST
BioAge Labs Market Cap
BioAge Labs has a market cap or net worth of $416.28 million as of December 5, 2025. Its market cap has decreased by -39.43% in one year.
Market Cap
416.28M
Enterprise Value
127.55M
1-Year Change
-39.43%
Ranking
Category
Stock Price
$11.61
Market Cap Chart
Since the IPO on September 26, 2024, BioAge Labs's market cap has decreased from $615.01M to $416.28M, a decrease of -32.31%. That is a compound annual growth rate of -27.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 416.28M | 100.55% |
| Dec 31, 2024 | 207.56M | -66.25% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |